PATENT CLAIM ANALYSIS

Application Number: 15916271
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["435", "006100"]

Abstract:
The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.

Claim (Index 19):
The system of  claim 16 , wherein the nucleic acid encoding the Type VI-D CRISPR-Cas effector protein operably linked to a promoter is in a vector.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.59259
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15467922', '15897089', '15783770', '15507176', '13842859']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.3114895201367377
- 35 USC 102 Novelty (BERT): 0.5487090486365614
- Combined Prediction Score: 0.3352114729867201
- Mean Citation Score: 379.938508
- Max Citation Score: 389.89246
- Similarity Product: 266.99811220386147

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test